Implant Site Nexplanon Reaction?


Autoria(s): Pedroso, C; Martins, I; Palma, F; Machado, AI
Data(s)

04/03/2016

04/03/2016

2015

Resumo

Nexplanon (Schering-Plough Limited/Merck Sharp & Dohme Limited (MSD)) is a long active reversible contraceptive method that provides effective contraception for 3 years. It consists of a single, flexible, rod-shaped implant, containing 68 mg etonogestrel. It is 4 cm long, consists of an ethylene vinyl acetate copolymer, a non-absorbable material, and also contains 15 mg of barium sulfate, which makes it visible by X-ray. We describe a case of a 39-year-old woman who experienced a local reaction to the barium sulfate in Nexplanon. She was given medical treatment, but only the removal of the implant resolved the symptoms. After removal there was gradual improvement and 72 h later the patient was asymptomatic. Allergic reaction to barium sulfate is extremely rare: until now, there have only been two cases associated with Nexplanon described in the literature.

Identificador

BMJ Case Rep. 2015 May 7;2015

http://hdl.handle.net/10400.17/2407

10.1136/bcr-2014-206256

Idioma(s)

eng

Publicador

BMJ Publishing Group

Direitos

openAccess

Palavras-Chave #MAC GIN #MAC OBS #Barium Sulfate/adverse effects #Contraceptive Agents, Female/administration & dosage #Contraceptive Agents, Female/adverse effects #Desogestrel/adverse effects #Device Removal #Drug Eruptions/etiology #Drug Implants/adverse effects #Treatment Outcome
Tipo

article